SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001628280-24-023908
Filing Date
2024-05-17
Accepted
2024-05-17 10:15:12
Documents
13
Period of Report
2024-05-17

Document Format Files

Seq Description Document Type Size
1 6-K a240517_6kxmorxvotingright.htm 6-K 11080
2 EX-99.1 exhibit_991.htm EX-99.1 6442
3 EX-99.2 exhibit_992.htm EX-99.2 5026
4 GRAPHIC exhibit_991001.jpg GRAPHIC 115888
5 GRAPHIC exhibit_991002.jpg GRAPHIC 129703
6 GRAPHIC exhibit_991003.jpg GRAPHIC 124211
7 GRAPHIC exhibit_991004.jpg GRAPHIC 90915
8 GRAPHIC exhibit_991005.jpg GRAPHIC 90992
9 GRAPHIC exhibit_991006.jpg GRAPHIC 21611
10 GRAPHIC exhibit_992001.jpg GRAPHIC 115754
11 GRAPHIC exhibit_992002.jpg GRAPHIC 125593
12 GRAPHIC exhibit_992003.jpg GRAPHIC 129134
13 GRAPHIC exhibit_992004.jpg GRAPHIC 52705
  Complete submission text file 0001628280-24-023908.txt   1396916
Mailing Address SEMMELWEISSTR. 7 PLANEGG 2M 82152
Business Address SEMMELWEISSTR. 7 PLANEGG 2M 82152 49 89 89927-0
MorphoSys AG (Filer) CIK: 0001340243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38455 | Film No.: 24958107
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)